TrialBlood advances2021

Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma.

Kristine A Frerichs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.